Tell Me Something Interesting Interview with the EULAR former President, Prof Daniel Aletaha 1 Jun 202522 Jul 2025 Anastasia Madenidou: Hello Professor Aletaha, and thank you for accepting our invitation to be interviewed. While I’m sure everyone within EMEUNET knows who you are, you may be interested to…
Annals of the Rheumatic Diseases… Spring 2025 Press Review – Annals of Rheumatic Diseases 12 May 202512 May 2025 December 2024 to March 2025 Author: Victoria Konzett & Mustafa Ekici Risk of developing psoriatic arthritis in patients with psoriasis initiating treatment with different classes of biologics Gisondi P, et al.…
Arthritis and Rheumatology… Spring 2025 Press Review – Arthritis & Rheumatology 12 May 2025 December 2024 to March 2025 Authors: Clementina López-Medina and Rym Abida Clinical factors associated with pneumocystis pneumonia despite its primary prophylaxis: When to stop prophylaxis? Kim, JY et al. (doi:10.1002/art.43167/abs) aimed…
Arthritis Research and Therapy… Spring 2025 Press Review – Arthritis Research & Therapy 12 May 2025 December 2024 to March 2025 Authors: Antony Psarras and Rositsa Dacheva Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis: results from nine European…
Press Review… Spring 2025 Press Review – Lancet Rheumatology 12 May 2025 December 2024 to March 2025 Author: Antony Psarras and Rositsa Dacheva Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised,…
Miscellaneous… Spring 2025 Press Review – Miscellaneous 12 May 2025 December 2024 to March 2025 Authors: Valentina Pucino and Jacob Koopman A Phase-3 Study on the Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis Furie R, et al. (doi:10.1056/NEJMoa2410965) conducted…
Rheumatology (Oxford) Spring 2025 Press Review – Rheumatology (Oxford) 12 May 2025 December 2024 to March 2025 Authors: Slaverio La Bella & Stephanie Ling Immune checkpoint inhibitors-induced large vessel vasculitis: clinical characteristics and management from a European multicentre study Immune checkpoint inhibitors (ICIs)…
Press Review… Spring 2025 Press Review – Seminars in Arthritis and Rheumatism 12 May 2025 December 2024 to March 2025 Authors: Slaverio La Bella & Stephanie Ling Real-world effectiveness of nintedanib in RA-ILD Atienza-Mateo B, et al. (doi:10.1016/j.semarthrit.2025.152710) assessed the real-world effectiveness and safety of nintedanib…
Tell Me Something Interesting Tell Me Something Interesting: A Weekend in Paris that Changed How I Teach 12 May 202513 May 2025 In November 2022, I had the privilege of attending the 4th Intensive Assessment & Teaching Seminar for EULAR Authors and Convenors in Paris. This was a joint seminar for EULAR…
rheumavision Finalists for RheumaVision 2025! 12 May 202512 May 2025 With great joy and pride, EMEUNET is now ready to release the finalists of RheumaVision 2025, the novel initiative for EMEUNET members celebrating presentation skills and knowledge sharing in Rheumatology. After enjoying the innovative…